Topics

Videos

In the second part of her interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, discusses the best practices that compliance teams should consider as the end of the stabilization period approaches this November. 

HDA 2024 Traceability Seminar: Best Practices Amid the Forthcoming Stabilization Period

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, highlights the hard-hitting points that she anticipated will be covered during her session at the 2024 HDA Traceability Seminar. 

HDA 2024 Traceability Seminar: Legal Advice for DSCSA Compliance Teams

Articles

How can industry stakeholders ensure the quality and supply chain security of existing product?

Unpacking the High Cost of GLP-1 Drugs

Panel offers suggestions on how compliance teams should be considering handling SOPs, stabilization, and much more.

HDA 2024 Traceability Seminar: A Legal Perspective Regarding DSCSA

Session uncovers distributors’ experiences with the Waiver, Exception, or Exemption request process, and how these affect the overall supply chain. 

HDA 2024 Traceability Seminar: DSCSA Implementation and Readiness

The agency provides an update surrounding the Act’s implementation efforts.

HDA 2024 Traceability Seminar: An FDA Perspective on DSCSA

In the final part of his Pharma Commerce video interview, Michael Rowe, Two Labs’  Senior Director of DSCSA/Serialization Compliance Services, comments on other ways to limit ‘bad actors’ attempts to sneak counterfeit drugs into the supply chain, aside from the DSCSA.

Keeping Counterfeit Goods Out of the Supply Chain

In this part of his Pharma Commerce video interview, Michael Rowe, Two Labs’  Senior Director of DSCSA/Serialization Compliance Services, predicts the likelihood of stabilization period postponement. 

Extending the Stabilization Period

In this part of his Pharma Commerce video interview, Michael Rowe, Two Labs’  Senior Director of DSCSA/Serialization Compliance Services, describes the outcome of the joint public meeting held by the Partnership for DSCSA Governance and the FDA.

Complying with the DSCSA

In this part of his Pharma Commerce video interview, Michael Rowe, Two Labs’  Senior Director of DSCSA/Serialization Compliance Services, discusses the state of affairs surrounding the Drug Supply Chain Security Act, along with opportunities for improvement. 

Brand & Product Security